Bal Pharma

Bal Pharma Limited, established in 1987, is a significant entity within the Pharmaceuticals and Healthcare industries, operating from Bengaluru, India. The company focuses on the manufacturing and global marketing of a broad spectrum of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). Its product portfolio is designed to address diverse therapeutic needs, serving both the Indian domestic market and international clients across various continents. Bal Pharma's strategic operations are geared towards delivering quality healthcare solutions through its extensive range of offerings.

The company's product catalog includes prescription drugs, generics, over-the-counter (OTC) medications, and intravenous infusion products. It provides specialized treatments in areas such as anti-infectives, pain management, respiratory care, and women's health, alongside specific brands for diabetic care like Diabend and Diabend M Group. Bal Pharma also offers herbal and ayurvedic preparations for conditions including prostate enlargement and renal calculi, as well as cardiovascular and dermatological products. Employing between 500 - 1,000 individuals, the company's operational strength is considerable, and you can Meet Bal Pharma's team to learn more about their organizational structure and leadership.

Bal Pharma's global footprint is substantial, with exports reaching Europe, Latin America, Africa, the Far East, and the Middle East. The company's stock is publicly traded under the ticker BSE: 524824. Its revenue stands at $35.9M, reflecting its market presence and operational scale. The company's product range also includes APIs for therapeutic areas such as anti-histamine, platelet inhibitor, and anti-diabetic treatments, further solidifying its position in the pharmaceutical supply chain.